T. Rowe Price Mid Cap Growth Portfolio ALNY Holdings History
T. Rowe Price Mid Cap Growth Portfolio's Alnylam Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Brighthouse Funds Trust I held 68,107.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $18.39 Mil. This investment constitutes 1.72% of their stock portfolio, and Brighthouse Funds Trust I now holds 0.05% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.
The initial trade took place in 2019Q3. And since then T. Rowe Price Mid Cap Growth Portfolio has made 10 purchases of ALNY, at an average price of $118.75, for a total of 94,800.00 shares. In addition, there have been 7 sales at an average price of $179.08 for 26,693.00 shares. Based on historical transaction data and ALNY's current price of $331.91, T. Rowe Price Mid Cap Growth Portfolio's estimated gain on his ALNY holdings is $16.13 Mil, reflecting a 143.27% gain to date.
T. Rowe Price Mid Cap Growth Portfolio ALNY ($331.91) Holding Chart
T. Rowe Price Mid Cap Growth Portfolio ALNY ($331.91) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
